Acute inflammation is a recognised part of normal wound healing. However, when
inflammation fails to resolve and a chronic inflammatory response is established this …

Infectious diseases after solid organ transplantation (SOT) are a significant cause of
morbidity and reduced allograft and patient survival; however, the influence of infection on …

Bronchiolitis obliterans syndrome (BOS) is a major complication of lung transplantation that
is associated with poor survival. The International Society for Heart and Lung …

Background Prior studies have shown that patients with pulmonary fibrosis with mutations in
the telomerase genes have a high rate of certain complications after lung transplantation …

Lung transplantation has become an accepted therapeutic procedure for the treatment of
end‐stage pulmonary parenchymal and vascular disease. Despite improved survival rates …

Background Community-acquired respiratory virus (CARV) infections occur frequently after
lung transplantation and may adversely impact outcomes. We hypothesized that while …

BACKGROUND: Voriconazole has been used for prevention and treatment of fungal
infections in patients after lung transplantation. We postulate that long-term use of …

Background Pulmonary non-tuberculous mycobacterial (NTM) infection is relatively common
after lung transplantation, but the effect on mortality remains undetermined. Herein we …

Lung transplantation offers a lifesaving option for patients with end-stage lung disease, but it
is marred by a high risk of post-transplant infections, particularly involving multidrug-resistant …

Rationale: Pseudomonas aeruginosa is the most commonly isolated gram-negative
bacterium after lung transplantation and has been shown to up-regulate glutamic acid …